Gene Symbol | LRRC40 |
---|---|
Entrez Gene | 55631 |
Alt Symbol | dJ677H15.1 |
Species | Human |
Gene Type | protein-coding |
Description | leucine rich repeat containing 40 |
Other Description | leucine-rich repeat-containing protein 40 |
Swissprots | Q9NXC1 Q9NSK1 Q9BTR7 Q9H9A6 |
Accessions | EAX06460 Q9H9A6 AI015897 AK000338 BAA91094 AK022951 BAB14326 AK225337 AL162076 CAB82410 BC003407 AAH03407 BC008586 AAH08586 DA310461 JF432343 ADZ15560 XM_005271013 XP_005271070 XM_011541762 XP_011540064 XM_011541763 XP_011540065 NM_017768 NP_060238 |
LRRC40 CRISPR/Cas9 KO Plasmid (h) - sc-412559 from Santa Cruz Biotechnology
|
||||||||
LRRC40 HDR Plasmid (h) - sc-412559-HDR from Santa Cruz Biotechnology
|
||||||||
LRRC40 Double Nickase Plasmid (h) - sc-412559-NIC from Santa Cruz Biotechnology
|
||||||||
LRRC40 Double Nickase Plasmid (h2) - sc-412559-NIC-2 from Santa Cruz Biotechnology
|
||||||||
LRRC40 CRISPR Activation Plasmid (h) - sc-412559-ACT from Santa Cruz Biotechnology
|
||||||||
LRRC40 CRISPR Activation Plasmid (h2) - sc-412559-ACT-2 from Santa Cruz Biotechnology
|
||||||||
LRRC40 Lentiviral Activation Particles (h) - sc-412559-LAC from Santa Cruz Biotechnology
|
||||||||
LRRC40 Lentiviral Activation Particles (h2) - sc-412559-LAC-2 from Santa Cruz Biotechnology
|
||||||||
LRRC40 siRNA (h) - sc-88575 from Santa Cruz Biotechnology
|
||||||||
LRRC40 shRNA Plasmid (h) - sc-88575-SH from Santa Cruz Biotechnology
|
||||||||
LRRC40 shRNA (h) Lentiviral Particles - sc-88575-V from Santa Cruz Biotechnology
|
||||||||
MISSION® esiRNA - EHU029021 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit - CKOZFN12739 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit, ZFN plasmid only - CKOZFND12739 from Sigma-Aldrich
|
||||||||
LRRC40 siRNA (Human) - CRJ0790 from Cohesion Biosciences
|
||||||||
shRNA set against Human LRRC40 (NM_017768.4) - SHH334535 from Creative biogene
|
||||||||
LRRC40 shRNA Plasmid (Human) - CHJ0790 from Cohesion Biosciences
|
||||||||
LRRC40 miRNA 3'UTR clone - MiUTR3H-15403 from Creative biogene
|
||||||||